GleamWall
中文EN

OFIX Orthofix Medical Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 884624 · Fiscal year ends 12/23

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.1%
TTM net income YoY62.2%
TTM EPS YoY63.7%
Revenue 3-yr CAGR7.7%
Net income 3-yr CAGR—

Margins

Gross margin70.9%
Operating margin-2.5%
Net margin-5.4%
FCF margin-5.3%
EBITDA margin3.9%

Returns

ROE-10.3%
ROA-5.3%
ROIC (approx.)-2.9%
Asset turnover0.99x

Leverage & solvency

Liabilities / assets49.8%
Debt / equity0.52x
Current ratio3.11x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.09x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue5.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$822.31M$799.49M
Cost of revenue$256.30M$253.61M
Gross profit$566.02M$545.88M
R&D expense$65.85M$73.64M
SG&A expense$554.33M$532.52M
Operating income-$81.43M-$84.62M
Pretax income-$90.81M-$123.88M
Income tax$1.38M$2.12M
Net income-$92.19M-$126.00M
EBITDA-$4.11M-$24.56M
EPS (basic)-2.33-3.30
EPS (diluted)-2.33-3.30
Weighted avg. shares (diluted)39.60M38.13M
Banking
Net interest income-$17.49M-$29.63M
Provision for credit losses$2.25M$2.00M
Balance sheet
Cash & equivalents$82.03M$83.24M
Receivables$135.75M$134.71M
Inventory$172.32M$189.45M
Current assets$416.85M$433.29M
PP&E, net$129.40M$139.80M
Goodwill$194.93M$194.93M
Intangibles$72.77M$98.80M
Total assets$850.65M$893.29M
Current liabilities$170.48M$168.63M
Short-term debt$0$0
Long-term debt$157.39M$157.01M
Total debt$157.39M$157.01M
Total liabilities$400.61M$390.17M
Shareholders' equity$450.04M$503.12M
Net debt$75.37M$73.78M
Shares outstanding39.83M38.49M
Cash flow statement
Operating cash flow$33.35M$25.79M
Capital expenditure$34.63M$34.88M
Free cash flow-$1.28M-$9.09M
Investing cash flow-$34.60M-$27.58M
Financing cash flow-$786,000$50.71M
Depreciation & amortization$77.32M$60.06M
Stock-based compensation$28.69M$32.45M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.